A wide range of adjunct therapies after botulinum toxin administration have been proposed. The aim of the present paper is to provide an overview of major writings dealing with adjuvant (non-pharmacological) treatments associated with botulinum toxin for managing spasticity in order to provide some up-to-date information about the usefulness of the most commonly used procedures
Abstract Introduction: The standard treatment for post-stroke spasticity (PSS) is rehabilitation. Bo...
Background/Aims:To compare patient outcomes following botulinum toxin (BoNT) injection by either phy...
Botulinum toxin is the most powerful toxin ever known. Its huge potential has been used in the last ...
Background and objective: A wide range of adjunct therapies after botulinum toxin administration hav...
BACKGROUND AND OBJECTIVE: A wide range of adjunct therapies after botulinum toxin administration ha...
BACKGROUND: Botulinum toxin (BTX) injection alone is not sufficient to treat spasticity in children,...
Background Botulinum toxin A (BoNT-A) injections are increasingly used to treat muscle spasticity an...
Botulinum toxin type A (BoNT-A) represents a first-line treatment for spasticity, a common disabling...
Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A...
Botulinum toxin injection is a well tolerated, safe and effective procedure in the treatment of foca...
Spasticity with muscle paresis and loss of dexterity is a common feature of upper motor neuron syndr...
Background. Botulinum toxin A (BoNT-A) injections are increasingly used to treat muscle spasticity a...
Botulinum toxin therapy is useful in the treatment of post stroke spasticity as seen in many clinica...
AimTo conduct a systematic review of the impact of different injection-guiding techniques on the eff...
Botulinum toxin type A (BoNT-A) represents the gold standard therapy for focal spasticity and relate...
Abstract Introduction: The standard treatment for post-stroke spasticity (PSS) is rehabilitation. Bo...
Background/Aims:To compare patient outcomes following botulinum toxin (BoNT) injection by either phy...
Botulinum toxin is the most powerful toxin ever known. Its huge potential has been used in the last ...
Background and objective: A wide range of adjunct therapies after botulinum toxin administration hav...
BACKGROUND AND OBJECTIVE: A wide range of adjunct therapies after botulinum toxin administration ha...
BACKGROUND: Botulinum toxin (BTX) injection alone is not sufficient to treat spasticity in children,...
Background Botulinum toxin A (BoNT-A) injections are increasingly used to treat muscle spasticity an...
Botulinum toxin type A (BoNT-A) represents a first-line treatment for spasticity, a common disabling...
Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A...
Botulinum toxin injection is a well tolerated, safe and effective procedure in the treatment of foca...
Spasticity with muscle paresis and loss of dexterity is a common feature of upper motor neuron syndr...
Background. Botulinum toxin A (BoNT-A) injections are increasingly used to treat muscle spasticity a...
Botulinum toxin therapy is useful in the treatment of post stroke spasticity as seen in many clinica...
AimTo conduct a systematic review of the impact of different injection-guiding techniques on the eff...
Botulinum toxin type A (BoNT-A) represents the gold standard therapy for focal spasticity and relate...
Abstract Introduction: The standard treatment for post-stroke spasticity (PSS) is rehabilitation. Bo...
Background/Aims:To compare patient outcomes following botulinum toxin (BoNT) injection by either phy...
Botulinum toxin is the most powerful toxin ever known. Its huge potential has been used in the last ...